SLC2A1 and breast carcinoma: CircKLHL24 can inhibit the proliferation and migration of breast cancer cells, downregulate the levels of HK2, GLUT1 and LDHA, and upregulate the expression of ALX4 by competitively binding miR-1204, thereby achieving tumor inhibition [89].